Atezolizumab Market Is Estimated To Witness High Growth Owing To...

ha aggiunto un file Altre informazioni

2023-11-27 13:31:51 -

Atezolizumab Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Cancer

Market Overview:Atezolizumab is a monoclonal antibody developed by Roche for the treatment of various types of cancer including lung cancer, bladder cancer, Hodgkin's lymphoma and triple-negative breast cancer. It blocks the interaction between PD-L1 and PD-1 receptors, enhancing the anti-tumor activity of T-cells. Atezolizumab is administered through intravenous injection and is used as a...

0 Commenti 0 condivisioni 1139 Views 0 Anteprima